214 related articles for article (PubMed ID: 18074738)
1. Expression of Bax protein in gastric carcinomas. A clinicopathological and immunohistochemical study.
Anagnostopoulos GK; Stefanou D; Arkoumani E; Chalkley L; Karagiannis J; Paraskeva K; Mathou N; Dellaporta E; Tsianos E; Agnantis NJ
Acta Gastroenterol Belg; 2007; 70(3):285-9. PubMed ID: 18074738
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
[TBL] [Abstract][Full Text] [Related]
3. [Immunohistochemical expression of bcl-2, bcl-xL, bax, p53 proteins in gastric adenoma and adenocarcinoma].
Lee DS; Kang SB; Baek JT; Nam SW; Lee KM; Ahn BM; Lee EH; Han SW; Chung IS
Korean J Gastroenterol; 2005 Jun; 45(6):394-400. PubMed ID: 15973073
[TBL] [Abstract][Full Text] [Related]
4. AKR1B10, a good prognostic indicator in gastric cancer.
Yao HB; Xu Y; Chen LG; Guan TP; Ma YY; He XJ; Xia YJ; Tao HQ; Shao QS
Eur J Surg Oncol; 2014 Mar; 40(3):318-24. PubMed ID: 24406159
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of p53 is associated with growth pattern and prognosis in advanced gastric cancer.
Ichiyoshi Y; Oiwa H; Tomisaki S; Sakaguchi Y; Ohno S; Maehara Y; Sugimachi K
Hepatogastroenterology; 1997; 44(14):546-53. PubMed ID: 9164535
[TBL] [Abstract][Full Text] [Related]
6. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y
Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717
[TBL] [Abstract][Full Text] [Related]
7. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
8. Should lymph node micrometastasis be considered in node staging for gastric cancer?: the significance of lymph node micrometastasis in gastric cancer.
Lee CM; Cho JM; Jang YJ; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Kim JH
Ann Surg Oncol; 2015 Mar; 22(3):765-71. PubMed ID: 25201506
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of intratumoral natural killer cells in gastric carcinoma.
Ishigami S; Natsugoe S; Tokuda K; Nakajo A; Che X; Iwashige H; Aridome K; Hokita S; Aikou T
Cancer; 2000 Feb; 88(3):577-83. PubMed ID: 10649250
[TBL] [Abstract][Full Text] [Related]
10. The prognostic impact of isolated tumor cells in lymph nodes of T2N0 gastric cancer: comparison of American and Japanese gastric cancer patients.
Fukagawa T; Sasako M; Shimoda T; Sano T; Katai H; Saka M; Mann GB; Karpeh M; Coit DG; Brennan MF
Ann Surg Oncol; 2009 Mar; 16(3):609-13. PubMed ID: 19137375
[TBL] [Abstract][Full Text] [Related]
11. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
[TBL] [Abstract][Full Text] [Related]
12. High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: comparison with non-cancerous lesions.
Ichinoe M; Mikami T; Yoshida T; Igawa I; Tsuruta T; Nakada N; Anzai N; Suzuki Y; Endou H; Okayasu I
Pathol Int; 2011 May; 61(5):281-9. PubMed ID: 21501294
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
14. [Risk factors and prognostic impact of No.12 lymph node metastasis in cases with curable advanced distal gastric cancer].
Wu H; Wu WH; Xu JB; Zhang XH; Wang L; Ma JP; Chen CQ; Cai SR; He YL; Zhan WH
Zhonghua Yi Xue Za Zhi; 2013 Dec; 93(48):3847-51. PubMed ID: 24548446
[TBL] [Abstract][Full Text] [Related]
15. Correlation of decreased expression of PHLDA1 protein with malignant phenotype of gastric adenocarcinoma.
Zhao P; Lu Y; Liu L
Int J Clin Exp Pathol; 2015; 8(5):5230-5. PubMed ID: 26191222
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and prognostic significance of MUC-2, MUC-4 and MUC-5AC expression in japanese gastric carcinomas.
Xiao LJ; Zhao S; Zhao EH; Zheng X; Gou WF; Xing YN; Takano Y; Zheng HC
Asian Pac J Cancer Prev; 2012; 13(12):6447-53. PubMed ID: 23464473
[TBL] [Abstract][Full Text] [Related]
17. Image cytometric bcl-2:bax and bcl-2:bcl-x ratios in invasive breast carcinoma: correlation with prognosis.
Schiller AB; Clark WS; Cotsonis G; Lawson D; DeRose PB; Cohen C
Cytometry; 2002 Aug; 50(4):203-9. PubMed ID: 12210599
[TBL] [Abstract][Full Text] [Related]
18. ADAM 10 is associated with gastric cancer progression and prognosis of patients.
Wang YY; Ye ZY; Li L; Zhao ZS; Shao QS; Tao HQ
J Surg Oncol; 2011 Feb; 103(2):116-23. PubMed ID: 21259244
[TBL] [Abstract][Full Text] [Related]
19. Akt and Cks1 are related with lymph node metastasis in gastric adenocarcinoma.
Lee SW; Kang SB; Lee DS; Lee JU
Hepatogastroenterology; 2013 Jun; 60(124):932-7. PubMed ID: 23321124
[TBL] [Abstract][Full Text] [Related]
20. Prognosis for gastric carcinomas with an insufficient number of examined negative lymph nodes.
Martinez-Ramos D; Calero A; Escrig-Sos J; Mingol F; Daroca-Jose JM; Sauri M; Arroyo A; Salvador-Sanchis JL; de Juan M; Calpena R; Lacueva FJ
Eur J Surg Oncol; 2014 Mar; 40(3):358-65. PubMed ID: 24075824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]